Dysregulated ARID1A expression can be detected in multiple malignancies, including gastric cancer, bladder cancer, and especially LUAD, ARID1A loss is associated with the significant enhancement of tumor metastasis and a poor prognosis [7]. Here, ARID1A is linked to urinary bladder cancer.